Dioum, E. M., Schneider, K. L., Vigerust, D. J., Cox, B. D., . . . Furman, D. (2022). Oats lower age-related systemic chronic inflammation (iAge) in adults at risk for cardiovascular disease. Nutrients, 14(21), 4471. doi:10.3390/nu14214471
Liska, D. J, Dioum, E., Chu, Y., Mah, E. (2022). Narrative review on the effects of oat and sprouted oat components on blood pressure. Nutrients, 14(22), 4772. doi:10.3390/nu14224772
Wolever, T. M. S., Rahn, M., Duom, E. H., Spruill, S. E., . . . Chu, Y. (2021). An oat β-glucan beverage reduces LDL cholesterol and cardiovascular disease risk in men and women with borderline high cholesterol: A double-blind, randomized, controlled clinical trial. The Journal of Nutrition, 151(9), 2655–2666. doi:10.1093/jn/nxab154
Xu, D., Wang, S., Feng, M., Shete, V., . . . Yang, Y. (2021). Serum metabolomics reveals underlying mechanisms of cholesterol-lowering effects of oat consumption: A randomized controlled trial in a mildly hypercholesterolemic population. Molecular Nutrition & Food Research, 65(9). doi:10.1002/mnfr.202001059
Xu, D., Feng, M., Chu, Y., Wang, S., . . . Yang, Y. (2021). The prebiotic effects of oats on blood lipids, gut microbiota, and short-chain fatty acids in mildly hypercholesterolemic subjects compared with rice: A randomized, controlled trial. Frontiers in Immunology, 12. doi:10.3389/fimmu.2021.787797
Fulgoni, V. L., Brauchla, M., Fleige, L., & Chu, Y. (2020). Association of whole-grain and dietary fiber intake with cardiometabolic risk in children and adolescents. Nutrition and Health, 26(3), 243-251. doi:10.1177/0260106020928664
Mathews, R., Kamil, A., & Chu, Y. (2020). Global review of heart health claims for oat β-glucan products. Nutrition Reviews, 78(S1), 78-97. doi:10.1093/nutrit/nuz069
Mathews, R., & Chu, Y. (2020). Global review of whole grain definitions and health claims. Nutrition Reviews, 78(S1), 98-106. doi:10.1093/nutrit/nuz055
Joyce, S. A., Kamil, A., Fleige, L., & Gahan, C. G. M. (2019). The cholesterol-lowering effect of oats and oat β-glucan: Modes of action and potential role of bile acids and the microbiome. Frontiers in Nutrition, 6, 171. doi:10.3389/fnut.2019.00171
Olson, A., Frankenfeld, C. L., Wallace, T. C., & Johnson, J. (2018). Assessment of oats and milk on markers of cardiovascular disease: National Health and Nutrition Examination Survey 1999-2014 data sets. Nutrition Today, 53(6), 293-299. doi:10.1097/NT.0000000000000308
Earnshaw, S. R., McDade, C. L., Chu, Y., Fleige, L. E., & Sievenpiper, J. L. (2017). Cost-effectiveness of maintaining daily intake of oat β-glucan for coronary heart disease primary prevention. Clinical Therapeutics, 39(4), 804-818.e3. doi:10.1016/j.clinthera.2017.02.012
Gulati, S., Misra, A., & Pandey, R. M. (2017). Effects of 3 g of soluble fiber from oats on lipid levels of Asian Indians - A randomized controlled, parallel arm study. Lipids in Health and Disease, 16, 71. doi:10.1186/s12944-017-0460-3
Zhang, J., Li, L., Song, P., Wang, C., . . . Kurilich, A. (2012). Randomized controlled trial of oatmeal consumption versus noodle consumption on blood lipids of urban Chinese adults with hypercholesterolemia. Nutrition Journal, 11, 54. doi:10.1186/1475-2891-11-54
Rendeiro, C., Dong, H., Saunders, C., Harkness, L., . . . Spencer, J. P. E. (2016). Flavanone-rich citrus beverages counteract the transient decline in postprandial endothelial function in humans: A randomised, controlled, double-masked, cross-over intervention study. British Journal of Nutrition, 116(12), 1999-2010. doi:10.1017/S0007114516004219
Slimko, M. L., & Mensah, G. A. (2010). The role of diets, food, and nutrients in the prevention and control of hypertension and prehypertension. Cardiology Clinics, 28(4), 665-674. doi:10.1016/j.ccl.2010.08.001